Rchr
J-GLOBAL ID:201601002259419669   Update date: Sep. 24, 2024

Kaikita Koichi

Kaikita Koichi
Research field  (1): Cardiology
Research keywords  (6): 心筋虚血再灌流障害 ,  冠攣縮性狭心症 ,  虚血性心疾患 ,  Myocardial ischemia reperfusion injury ,  Vasospastic angina ,  Ischemic heart disease
Research theme for competitive and other funds  (9):
  • 2020 - 2023 経カテーテル大動脈弁留置周術期の総合的血栓形成能評価法による至適抗血栓療法の確立
  • 2015 - 2018 Establishment of optimal antithrombotic therapy by using novel thrombus formation analysis system in patients with cardiovascular disease
  • 2012 - 2015 Rapid detection of CYP2C19 reduced-function gene polymorphism and the establishment of optimal medical therapy in patients with acute coronary syndrome
  • 2009 - 2011 Serial changes in platelet activation biomarkers and the effects of anti-platelet therapy in percutaneous coronary intervention
  • 2004 - 2007 Application of CD204 (scavenger receptor) to histopathological diagnosis and production of new anti-macrophage antibodies
Show all
Papers (262):
  • Naoto Kuyama, Satoshi Araki, Koichi Kaikita, Nobuhiro Nakanishi, Naoya Nakashima, Shinsuke Hanatani, Yuichiro Arima, Masahiro Yamamoto, Taishi Nakamura, Eiichiro Yamamoto, et al. Mineralocorticoid Receptor Blocker Prevents Mineralocorticoid Receptor-Mediated Inflammation by Modulating Transcriptional Activity of Mineralocorticoid Receptor-p65-Signal Transducer and Activator of Transcription 3 Complex. Journal of the American Heart Association. 2024. 13. 18
  • Toshihiro Tsuruda, Hiroshi Nakada, Yoshimasa Yamamura, Yunosuke Matsuura, Miyuki Ogata, Miyo Tanaka, Yosuke Suiko, Soichi Komaki, Hiroki Tanaka, Kohei Moribayashi, et al. Basal inferoseptal segment is highly susceptible to deformation in the clinical spectrum of transthyretin-derived amyloid cardiomyopathy. European heart journal open. 2024. 4. 5. oeae076
  • Kenichi Matsushita, Sunao Kojima, Kyoko Hirakawa, Noriaki Tabata, Miwa Ito, Kenshi Yamanaga, Koichiro Fujisue, Tadashi Hoshiyama, Shinsuke Hanatani, Daisuke Sueta, et al. Differential impact of diabetes mellitus on in-hospital mortality based on circadian variation in acute myocardial infarction. Hellenic Journal of Cardiology. 2024
  • Yasuhiro Otsuka, Masanobu Ishii, Noriaki Tabata, Seitaro Oda, Masafumi Kidoh, Yuichiro Shirahama, Koichi Egashira, Naoto Kuyama, Taku Rokutanda, Katsuo Noda, et al. Subclinical leaflet thrombus in patients with severe aortic stenosis and atrial fibrillation -ENRICH-AF TAVI study. Scientific reports. 2024. 14. 1. 14902-14902
  • Shintaro Izumoto, Kazumasa Kurogi, Kohei Moribayashi, Soichi Komaki, Yunosuke Matsuura, Nobuyasu Yamamoto, Toshihiro Tsuruda, Koichi Kaikita. Rewiring of the dissected branch along the jailed balloon technique in provisional stenting for true coronary bifurcation lesions. Cardiovascular Revascularization Medicine: Interesting Cases. 2024. 2. 100018-100018
more...
MISC (347):
more...
Books (1):
  • 急性冠症候群 (筒井裕之、阿古潤哉 編集)
    MEDICAL VIEW 2018
Lectures and oral presentations  (5):
  • 令和時代の新しい抗血栓療法 - AFIRE Studyがその扉を開く-
    (ARIA2019 2019)
  • 心房細動合併安定冠動脈疾患 における至適抗血栓療法 - AFIRE Studyが導くエビデンス -
    (第28回日本心血管インターベンション治療学会 2019)
  • 冠攣縮性狭心症ガイドライン -現状と今後の展望-
    (第67回日本心臓病学会 2019)
  • LCZ696 (sacubitril/valsartan) Protects Against Left Ventricular Remodeling After Experimental Acute Myocardial Infarction
    (2019)
  • Optimal Drug Therapy for Vasospastic Angina With and Without Organic Stenosis
    (2018 Fall Conference, ISCP Korea Chapter, Seoul 2018)
Works (19):
  • 循環器疾患に随伴する後天性フォンウィルブランド症候群の診断 基準・重症度分類の確立
    2016 - 2019
  • 循環器疾患における新規血栓形成能測定システムを用いた至適抗血栓療法の確立
    2015 - 2018
  • 急性冠症候群におけるCYP2C19機能喪失遺伝子の迅 速検出と至適薬物治療法の確立
    2012 - 2015
  • 冠動脈形成術前後における血小板マーカーの変動と抗血小板療法の有効性に関する検討
    2009 - 2012
  • 生体内投与至適条件下におけるインテリジェントナノDDSおよび超音波照射の安全性の確認
    2010 - 2011
more...
Committee career (1):
  • 2018/04 - 現在 日本循環器学会 特別正会員(FJCS)
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page